Endoscopic prediction of depth of tumor invasion in early gastric cancer in the upper third of the stomach.

Authors

null

Hee Seok Moon

Chungnam National University Hospital, Daejeon, South Korea;

Hee Seok Moon , Cnuhgi Cnuhgi

Organizations

Chungnam National University Hospital, Daejeon, South Korea; , Chungnam national University Hospital, Daejeon, South Korea;

Research Funding

No funding received
None.

Background: The endoscopic features of early gastric cancer (EGC) arising from the upper third of the stomach (upper body, fundus, and cardia) has not been well studied. If EGC in the upper third of the stomach can be predicted to have invaded the mucosal (M) or submucosal (SM) layer, endoscopic or surgical treatment can be determined. This study evaluated the endoscopic features of EGC in the upper third of the stomach as well as risk factors for SM invasion. Methods: We retrospectively reviewed patients' medical records from a single tertiary hospital (Daejeon) and investigated endoscopic findings and clinical data. Patients with EGC in the upper third of the stomach who underwent surgery or endoscopic resection between January 2016 and April 2022 were included. Logistic regression was used to determine the risk factors of the SM cancer group. Results: In total, 173 patients were enrolled in this study: 94 with SM cancer and 79 with M cancer. Risk factors for SM invasion determined by univariate logistic regression were clubbing of converging folds (OR 6.279, p=0.000), fusion of converging folds (OR 9.179, P=0.000), irregular nodule in the central lesion (OR 2.336, p=0.016), margin with elevation (OR 2.520, P=0.031), and ulceration (OR 9.686, p=0.000). However, in the multivariate logistic regression analysis, only ulceration was identified as a risk factor (OR 6.598, p=0.007). Conclusions: In EGC occurring in the upper third of the stomach, ulceration is a risk factor for SM invasion. Surgical treatment should be considered if this characteristic is present.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Therapeutics

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 406)

DOI

10.1200/JCO.2023.41.4_suppl.406

Abstract #

406

Poster Bd #

H9

Abstract Disclosures

Similar Abstracts

Abstract

2023 ASCO Gastrointestinal Cancers Symposium

Optimal interval of surveillance gastroscopy after endoscopic resection for gastric neoplasia: A multicenter cohort study.

First Author: Byung-Wook Kim

Abstract

2024 ASCO Gastrointestinal Cancers Symposium

Metachronous remnant gastric cancer after proximal gastrectomy.

First Author: Kenichi Ishizu

Abstract

2024 ASCO Gastrointestinal Cancers Symposium

Prevalence of modifiable risk factors of Hispanic adult patients admitted with gastric cancer in the US.

First Author: Alejandro Nieto Dominguez

Abstract

2024 ASCO Gastrointestinal Cancers Symposium

Clinical risk factors for splenic hilar nodal metastasis in remnant gastric cancer after distal gastrectomy.

First Author: Ryota Sakon